Chlorophyll2020

Which side of the pi-macrocycle plane of (bacterio)chlorophylls is favored for binding of the fifth ligand?

Photosynthesis research

confidence

Key findings

Structural and modeling study shows chlorophyll/bacteriochlorophyll favor binding of fifth ligand on the 'back' side of the macrocycle where C13(2)-methoxycarbonyl protrudes.

View source on PubMed (PMID 16228541) ↗

Sample size
34 photosynthetic proteins with (B)Chl cofactors
Population
Not applicable (structural/biochemical study)
Dosing
Not applicable
Duration
Not reported
Route
Not applicable
Blinding
not_reported
Controls
none
Drug class
porphyrin pigment
Full abstract

Reported crystallographic data and calculated molecular models indicated that chlorophyll (Chl) a and bacteriochlorophyll (BChl) a tend to bind the fifth ligand on the side of the macrocycle where the C13(2)-(R)-methoxycarbonyl moiety protrudes (denoting the 'back' side). The crystal structures of 34 photosynthetic proteins possessing (B)Chl cofactors revealed that most of Chl a and BChl a (and b) are coordinated by any peptidyl residue (e.g., histydyl-imidazolyl group), peptidyl backbone or water from the 'back' side. Almost all the cofactors that bind a water molecule as the fifth ligand in these proteins have a 'back' configuration. Theoretical model calculations for methyl chlorophyllide a (MeChlid a) and methyl bacteriochlorophyllide a (MeBChlid a) bound to an imidazole molecule indicated that the 'back' side is energetically favored for the ligand binding. These results are consistent with the fact that ethyl chlorophyllide a (EtChlid a) dihydrate crystal consists of the 'back' complex. The modeling also showed that both removal and stereochemical inverse of the C13(2)-methoxycarbonyl group affect the relative stability between the 'back' and 'face' complexes. The effect of the C13(2)-moiety on the choice of the macrocycle side for the ligand binding is discussed in relation to the function of P700.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.